Trademarkia Logo

Australia

AU$
Trademark Search
PROTAGONIST THERAPEUTICS

View On IPO.GOV.AU

PROTAGONIST THERAPEUTICS
Protected: Registered/protected

Last updated on 27 Jul 2024

Owner Info

Protagonist Therapeutics, Inc.

7707 Gateway Blvd. Suite 210

Newark CA 94560, UNITED STATES OF AMERICA

Serial Number

2433220 filed on 3 Jan 2024

Correspondent

Frances M. Jagla Christensen O'Connor Johnson Kindness

1201 Third Avenue, Suite 3600,

Seattle WA 98101,

UNITED STATES OF AMERICA

PROTAGONIST THERAPEUTICS

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocri Read More

Class [042]
Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine di Read More

Class [044]
Providing online information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare Read More

Mark Details

Serial Number

2433220

Registered On

3 Jan 2024

Renewal On

3 Jan 2034

Mark Type

WORD

Priority Claim (Convention Details)

Date

18 Dec 2023

Mark Type

US

Legal History

Show more

Status DateAction Taken
27th Jul 2024International Registration in Australia Protected correspondence sent
26th Jul 2024IP Right Registration Published
26th Jul 2024Status change to Registered/Protected
19th May 2024Application Accepted correspondence sent
19th May 2024IP Right has been Examined
19th May 2024IP Right Acceptance Published
8th Mar 2024Status change to Accepted
7th Mar 2024Examination expedited
7th Mar 2024Awaiting examination
7th Mar 2024IP Right Filed Published